Cure Lab, Inc.
Panel Discussion on Oncolytic Viruses
Thursday, January 26, 2006
Hyatt Regency Cambridge
Cambridge Room, second level
575 Memorial Drive
Cambridge, MA 02139

Participants:
Michael Blagosklonny, Ph.D., Ordway Research Institute, Inc.
Michael Borrelli, Ph.D., University of Arkansas for Medical Sciences
Stuart Calderwood, Ph.D., Harvard University
Herbert Cohen, Ph.D., Boston University School of Medicine
Petr Ilyinskii, Ph.D., Cure Lab, Inc.
Kim Lewis, Ph.D., Northeastern University
Igor Roninson, Ph.D., Ordway Research Institute, Inc.
Michael Sherman, Ph.D., Boston University School of Medicine
Alex Shneider, Ph.D., Cure Lab, Inc.
Michael Sitkovsky, Ph.D., Northeastern University

Moderator:
Galini Thoidis, Ph.D., Cure Lab, Inc.

Schedule:
8:30 am Continental Breakfast
9:00 am Alex Shneider, Ph.D., Opening Remarks
9:15 am Petr Ilyinskii, Ph.D. “Oncolytic Viruses: An Overview”
10:00 am Igor Roninson, Ph.D. “Identifying genetic elements with potential therapeutic activities”
10:45 am Michael Blagosklonny, Ph.D. “ Selective cancer therapy”
11:30 am Michael Sherman, Ph.D. “ Oncolytic viruses: Cure Lab’s ideas for the future”
12:30 am Continental Lunch
1:30 pm Part 1: “Brain-storming” and Open-ended Discussion
Part 2: Critical Comments
Part 3: Generating an oncolytic viruses “To-do” List for Cure Lab
Evening: Dinner with participants